Mitochondrial DNA Variants Predict Risk of Graft-Versus-Host Disease in MDS Patients Undergoing Allogeneic HCT

Key Points

• Graft-versus-host disease risk is significantly associated with specific mitochondrial DNA variants in patients.
• Key evidence shows that certain mitochondrial variants can predict donor and recipient compatibility outcomes.
• The assessment utilized genomic analysis of mitochondrial DNA from patients undergoing allogeneic hematopoietic cell transplantation.
• Highlights the need for better risk prediction methods in managing MDS patients undergoing transplant procedures.